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Abstract
Background: Epidemiological studies show that elevated levels of particulate matter in ambient air are highly
correlated with respiratory and cardiovascular diseases. Atmospheric particles originate from a large number of
sources and have a highly complex and variable composition. An assessment of their potential health risks and
the identification of the most toxic particle sources would require a large number of investigations. Due to ethical
and economic reasons, it is desirable to reduce the number of in vivo studies and to develop suitable in vitro
systems for the investigation of cell–particle interactions.
Methods:We present the design of a new particle deposition chamber in which aerosol particles are deposited onto
cell cultures out of a continuous air flow. The chamber allows for a simultaneous exposure of 12 cell cultures.
Results: Physiological conditions within the deposition chamber can be sustained constantly at 36–37C and 90–
95% relative humidity. Particle deposition within the chamber and especially on the cell cultures was determined
in detail, showing that during a deposition time of 2 hr 8.4% (24% relative standard deviation) of particles with a
mean diameter of 50nm [mass median diameter of 100 nm (geometric standard deviation 1.7)] are deposited on the
cell cultures, which is equal to 24–34% of all charged particles. The average well-to-well variability of particles
deposited simultaneously in the 12 cell cultures during an experiment is 15.6% (24.7% relative standard deviation).
Conclusions: This particle deposition chamber is a new in vitro system to investigate realistic cell–particle
interactions at physiological conditions, minimizing stress on the cell cultures other than from deposited par-
ticles. A detailed knowledge of particle deposition characteristics on the cell cultures allows evaluating reliable
dose–response relationships. The compact and portable design of the deposition chamber allows for measure-
ments at any particle sources of interest.
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Introduction
Aerosol particles present in the ambient atmosphereand engineered nanoparticles used in industrial pro-
cesses and consumer products are potentially involved in a
number of respiratory and cardiovascular diseases. The main
route of undesired uptake of submicrometer particles into the
body is via inhalation.(1) Epidemiological studies provide am-
ple and consistent evidence for a link between adverse health
effects and increased concentrations of ambient particles.(2–4)
There are indications for a specific toxicological role of ultrafine
or nanoparticles, i.e., particles with diameters of < 100nm.(5–7)
Health effects assumed to be associated with aerosol particles
are one of the major environmental public health issues in in-
dustrialized countries, especially as the environmental burden
of nanoparticles is likely to increase in the future.(8)
Besides atmospheric particles, a large number of en-
gineered nanoparticles are being introduced in industrial
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processes, many of them containing potentially toxic metals.
These engineered nanoparticles may become aerosolized at
some stage of their life cycle and pose additional health risks
for specific workplace settings, but also for the general
public.(9) It should be noted that real-life release mechanisms
may strongly alter the size distribution of such engineered
nanoparticles, and as a result of this they might not be
present in the atmosphere as nanometer-size particles or
have altered physical–chemical properties.
Mechanistic in vivo animal and in vitro studies support the
findings of epidemiological studies,(10–12) but the current
understanding on a cellular or biochemical level is still in-
complete. Thus, a thorough understanding of (nano)particle–
lung interactions is urgently needed. In addition, an
increasing use of aerosol particles for pharmaceutical drug
delivery requires a detailed understanding of particle depo-
sition and drug uptake processes via the lung.
Increasing diversity of engineered nanoparticles, phar-
maceutical aerosol drug delivery systems, and also the large
number of sources of atmospheric particles call for compre-
hensive investigations of particle–lung interactions. But an
extensive use of animal models is hampered by ethical,
technical, and economic reasons, and therefore in vitro tech-
niques are strongly favored. A realistic experimental setup to
assess aerosol particle–lung interactions and associated po-
tential toxic effects with in vitro studies should include the
following essential parts: (1) (nano)particles need to be de-
posited onto the cell cultures as real aerosol particles, i.e.,
from a continuous air flow at realistic particle concentrations,
composition, and size; (2) cell cultures used to assess nano-
particle effects need to closely mimic the complex multicell
structure of the human lungs(13,14); and (3) the exposure and
deposition scenario should mimic the corresponding pro-
cesses in the lungs as accurately as possible.
Current experimental procedures for in vitro particle
studies rarely meet these essential requirements, which
might result in severe biases when interactions between
particles and lung cells are interpreted. Particles are often
deposited onto lung cells all at once (e.g., pipetted). This does
not reflect the extended period of time during which particles
are usually deposited on the lung surface and results in often
unrealistically high particle concentrations in in vitro studies.
In addition, suspending particles in a solvent can substan-
tially alter their chemical and physical properties compared
with conditions where they are freely suspended in air.(13,14)
We present here a new instrument, which aims to mimic
(nano)particle deposition and interaction with lung cells in
in vitro experiments as accurately as possible compared with
conditions in the lung. A first version of our exposure system
introduced the concept of electrostatic deposition of bipo-
larly charged aerosol particles onto lung cell cultures from a
continuous air flow, which is much more efficient than dif-
fusional deposition.(15) Further, we demonstrated that the
associated very weak currents did not induce any cell effects.
We also showed that the particles were evenly deposited
onto the cell cultures, an essential aspect when toxicological
dose–effect relationships are established. Particles were
humidified [to > 80% relative humidity (RH)] and heated to
36–37C outside of the deposition chamber to mimic incu-
bator-like conditions.
In the significantly improved in vitro system described
here, the realistic particle deposition is further refined.
Essential parts of the experimental setup, i.e., aerosol
humidification, heating, and cell exposure, are combined
into one portable instrument, which allows performing
experiments outside the cell biology laboratory at any
particle source of interest. Besides a detailed description of
design and operation of the new deposition chamber, the
deposition efficiency of particles is evaluated in detail. This is
an essential aspect if biological responses are interpreted in a
toxicological context.
Materials and Methods
Design of the deposition chamber
A schematic of the deposition chamber is shown in Figure
1. The instrument consists of three subunits: a humidifier, a
distributor, and a cell chamber unit. Immediately after en-
tering the deposition chamber, the aerosol is humidified by
passing through a GORE-TEX tube (length, 10 cm; inner
diameter, 0.6 cm) that is immersed in a heated water bath (1.5
L, 18MO cm water). Thus, the aerosol flow is conditioned to
36–37C and 90–95% RH. In the distributor, the aerosol is
evenly divided into 12 circularly arranged delivery tubes
(inner diameter, 1 cm). When exiting the delivery tubes, the
aerosol passes over the cell cultures grown on filter inserts
[polyester membrane, 0.4 lm pore size; 24-mm Transwell
inserts (Corning, Vitaris, Baar, Switzerland) or 24-mm Fal-
con inserts (Becton Dickinson AG, Milian, Geneva, Swit-
zerland)] positioned approximately 2mm below each tube.
The filter inserts are placed in a home-built 12-well plate (for
the simultaneous exposure of 12 cell cultures), which is
routinely autoclaved before each cell culture exposure ex-
periment. All other parts of the deposition chamber, except
the short GORE-TEX tube, can also be sterilized, if required.
The air is pumped out of the chamber through a centrally
positioned outlet, which is connected to a membrane pump.
Total air flow rate is 600mL min - 1, i.e., 50mL min - 1 in each
FIG. 1. Design of the deposition chamber. The aerosol
particle deposition chamber consists of a cylindrical humid-
ifier, a distributor, and the cell chamber containing the 12-
well plate (5) and the delivery tubes (4) (see also Fig. 2a). The
chamber is heated in the water bath (3) as well as at the
bottom (6). The device is insulated by a polystyrene housing
(1). The continuous air flow from the aerosol source is hu-
midified by passing through a GORE-TEX tube (2). The flow
path of the aerosol is illustrated by the blue arrows.
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delivery tube. The deposition chamber is heated by a 120 W
resistor in the humidifier’s water bath, as well as a 6.2 W
silicone rubber thermofoil at the bottom of the chamber.
An insulating polystyrene housing (4 cm thickness) around
the entire deposition chamber assures temperature homoge-
neity within the instrument. Each of the 12 delivery tubes is
equipped with lead-throughs to allow for installation of op-
tical fibers to detect ciliary beat frequency online during the
particle exposure, as described in detail by Savi and co-
workers.(15) Potentially, also other optical signals, e.g., from
fluorescent markers, could be observed online with these op-
tical fibers. The radial design of the entire instrument assures
an even distribution of the particles to the 12 cell culture wells.
Before entering the deposition chamber, trace gases that
are potentially present in the aerosol (such as nitrogen oxides,
ozone, and volatile organic compounds) are removed by a
charcoal denuder to assure that observed biological effects are
due only to particles. Five percent CO2 (by volume) is added
to the aerosol flow to maintain the cell culture medium in the
physiological pH range. Particles then pass a 85Kr bipolar
charger (185MBq), which assures that the aerosol particles are
in charge equilibrium when they enter the deposition cham-
ber. After passing the bipolar charger, particles carry 1–2 el-
emental charges (positive or negative), which is very similar to
the particle charge equilibrium in the atmosphere.(15) This
charge results in a very low current deposited on the cell
culture, typically in the sub-femtoampere range, as discussed
in detail by Savi et al.,(15) and is not expected to affect the cell
cultures. Inside the deposition chamber in the cell chamber
unit, the charged particles are deposited evenly (as discussed
in detail by Savi et al.(15)) and efficiently onto the cell cultures
by applying an alternating square-wave electrical field of
4 kV cm-1 between an electrode below each well (diameter,
1.8 cm) and a fine metal mesh at the outlet of each delivery
tube as counter electrode (diameter, 1.2 cm). To avoid particle
losses, only stainless steel or conductive rubber tubing is used.
Particle generation
A thorough characterization of the deposition efficiency of
particles (i.e., the fraction of particles deposited out of the
aerosol flow) is essential to assess how many particles are
deposited on the cell cultures during an exposure experi-
ment. Only a precise knowledge of the particle deposition
efficiency allows the establishing of particle dose–cell ef-
fect relationships, the ultimate goal of many toxicological
particle–lung interaction studies.
For the deposition characterization experiments, adipic
acid aerosol particles were produced using a conventional
recirculation atomizer (model 3076, TSI, Shoreview, MN)
connected to a filtered air supply (model 3074, TSI). Adipic
acid particles were used for these experiments, because this
compound has favorable physical–chemical properties (see
below) and the size of the particles is representative of par-
ticles found in the ambient atmosphere. The inlet air pressure
for the atomizer was set to about 3 bar and the outlet flow
was 2.1 L min - 1. We kept the adipic acid concentration within
the nebulizer constant by using a large volume (1 L) of the
solution. The aerosol generator produced a stable aerosol,
which was checked by performing repetitive size distribution
measurements, before and after every experiment. Three 85Kr
sources placed after the atomizer (2· 74MBq, 1·185MBq)
were used to assure that the atomized particles are in charge
equilibrium. An aqueous solution (170lmol L- 1) of adipic
acid [hexanedioic acid: HOOC-(CH2)4-COOH] was atomized
for these measurements, generating particles with a diameter
mode of 50nm (number-weighted particle size distribution).
The mass-weighted mode was at about 100nm. Typical con-
centrations were 7- 8· 105 particles cm- 3 with a polydisperse
size distribution (sigma 1.7). Adipic acid has a very high
deliquescence point (*100% RH), and therefore the RH of
90–95% in the chamber does not affect the size distribution of
adipic acid particles.(16) The low vapor pressure of adipic acid
(about 9.8· 10-6 Pa at 296K)(17) assures that no adipic acid
evaporates after deposition. Particle number size distributions
between 15 and 760nm were measured with a scanning mo-
bility particle sizer (SMPS) consisting of an electrostatic clas-
sifier [differential mobility analyzer (DMA) model 3071A, TSI]
and a condensation particle counter (CPC model 3022A, TSI).
The sheath air flow rate was 3 L min- 1 and the sampled air
flow rate 0.3 L min- 1. One scan took 3min.
As the particle deposition efficiency is related to the total
amount of adipic acid particles entering the deposition
chamber in every experiment, a filter (Millipore FSW04700
Fluoropore PTFE 3 lm) sample of the total aerosol flow was
taken before and after each deposition experiment. At a flow
rate of 600mL min - 1, a filter sample of the nebulized aerosol
was collected during 15min (total aerosol volume collected:
9 L). The filter was positioned upstream of the deposition
chamber. The filter was extracted in 2mL of 0.05mM NaOH
solution, and the extract was then diluted by a factor of 10.
This solution was analyzed with ion chromatography cou-
pled to a mass spectrometer (IC/MS) like all other samples.
From the measured mass of adipic acid per milliliter, we
calculated the mass of adipic acid per cubic meter of air.
The comparison of IC/MS and SMPS measurements resulted
in an effective density for adipic acid of 0.5 g cm- 3, which
was used to convert the SMPS volume data into mass
concentrations.
IC/MS analysis
For a detailed quantification of the particles deposited on
the cell culture inserts and to assess the variability of the
deposition between the twelve inserts, the following chemi-
cal analysis method was developed: The adipic acid mass
deposited by the particles in the deposition chamber was
quantified with IC/MS. Particles were deposited in the de-
position chamber as in normal operation, except that the
filter membranes of the inserts (on which the cell cultures are
normally grown) were removed. The 12 wells were filled
with 3mL of an aqueous sodium hydroxide (NaOH) solution
up to the height where the filter membrane of the insert
would be located (see Fig. 2a). The solution had a pH of 9–10
(0.05mM), such that dissolved adipic acid deprotonates and
cannot evaporate. The aerosol flow in these deposition ex-
periments was 50mL min - 1 in each particle delivery tube
(600mL min - 1 in total), and the exposure time was 120min.
Three different settings were considered, as described in
Figure 2b: bypassing the entire deposition chamber (1) and
passing the aerosol through the deposition chamber with the
electrical field off (2) or on (3).
Particle deposition on the fine metal meshes at the end of
each particle delivery tube (i.e., at the counter electrode) was
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also quantified. Adipic acid particles were dissolved from the
meshes by immersing the ends of the delivery tubes for 5min
in aqueous NaOH solution (2mL, pH 9–10) filled into each
well of a separate 12-well plate.
The adipic acid concentration in the NaOH solutions was
then quantified with IC/MS using a guard column (AG11-
HC, Dionex, Sunnyvale, CA) and an analytical column
(AS11-HC, Dionex). The eluent (flow rate, 0.35mL min - 1)
consisted of an OH - gradient (0min, 0.95mM OH- ; 5min,
0.95mM OH- ; 15min, 15mM OH - ; 21min, 60mM OH - ;
23min, 60mM OH- ; 23.1min, 0.5mM OH- ; 29min, 0.5mM
OH - ). The gradient was generated online by an Eluent
Generator (EG40, Dionex) from an EluGen potassium hy-
droxide cartridge (EGC-KOH, Dionex) and ultrapure water
(18MO cm). After the analytical column, OH- anions were
suppressed by an anion self-regenerating suppressor (ASRS
300 2mm, Dionex). A conductivity detector and a quadru-
pole mass spectrometer with unity mass resolution were
used as detectors. The IC/MS instrument was calibrated by
direct injection of aqueous adipic acid standards (1.103,
10.95, and 109.6 ng mL - 1; corresponding to 7.5, 75, and
750 nM), and a first-order least-squares regression was fitted
to the data. The retention time of adipic acid was 19.9min.
The reproducibility of this method is 3.6%, which is the
standard deviation of three measurements of a 75 nM adipic
acid standard solution [i.e., within the concentration range of
our analyzed samples (20–200nM)]. Samples were injected via
a 100-lL sample loop without preconcentration step. The
comparison of IC/MS and SMPS measurements resulted in an
effective density of adipic acid in the particles of 0.5g cm–3.
Although the density of solid adipic acid in the bulk phase is
1.36 g cm–3, atomization and subsequent drying may lead to
fragmented particles with a low effective density.
Results and Discussion
Chamber operation
The 12-well plate containing the cell culture inserts is
easily inserted into the deposition chamber by opening the
bottom plate of the cell chamber (see Fig. 1). The insulating
polystyrene enclosure assures that a homogeneous temper-
ature and humidity are established quickly in the deposition
chamber after closing, as shown in Figure 3. The chamber
was first brought from room temperature to the set tem-
perature of 37C, which takes about 2 hr (Fig. 3, data at times
before exposure start). Then the chamber was opened for
about 4min, which is enough to exchange the cell cultures,
and closed again. The fast recovery of the desired tempera-
ture and humidity prevents condensation of water within the
chamber at high RH, which is crucial to avoid particle losses,
as well as temperature and humidity–induced stress for the
cells. Seventeen minutes after the chamber is closed, the
temperature reaches 35C and RH exceeds 85% (Fig. 3); after
30min, the temperature stays constant between 36C and
37C and RH between 90% and 95%, which allows the
FIG. 2. Experimental setup of particle deposition efficiency
measurements. (a) Schematic of experimental setup used to
quantify particle deposition in the wells and the particle
delivery tubes. Deposited particles were quantified with IC/
MS. (b) Three different settings of the aerosol flow were used
to quantify the overall particle deposition in the chamber
using an SMPS: (1) bypassing the deposition chamber (total
aerosol particle number, gray line); (2) passing the aerosol
through the deposition chamber without electrical field
(dotted line); and (3) passing the aerosol through the depo-
sition chamber with electrical field on (black line).
FIG. 3. Temporal evolution of temperature and RH during
exposure. After the deposition chamber is opened to replace
a 12-well plate, the temperature and RH recover rapidly, i.e.,
after 17min, temperature reaches 35C and RH exceeds 85%.
After 30min, temperature is between 36C and 37C and RH
between 90% and 95%, assuring optimal conditions for the
cell cultures. The deposition chamber was preconditioned,
and the replacement of a well plate typically takes about
4min.
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performance of cell exposure experiments for several hours.
This mimics physiological conditions in the airways very
well, and hence stress factors on the cells other than induced
by aerosol particles are minimized.(18) After a typical expo-
sure time of a few hours, the 12-well plate is removed from
the deposition chamber for further analysis of the cell
cultures.
In two recent studies, the deposition chamber was used to
expose various lung cell cultures to aerosol particles from
diesel exhaust, wood burning, and secondary organic aero-
sols. These experiments and the observed biological effects
are described by Gaschen and co-workers.(19)
Particle deposition characteristics
Overall particle losses in the deposition chamber. The
fraction of adipic acid particles (generated online with a
nebulizer) deposited within the entire deposition chamber,
with and without electrical field, was determined using an
SMPS. The experimental setup is shown in Figure 2b. Three
different experiments were performed: bypassing the depo-
sition chamber (1) and passing the aerosol through the de-
position chamber with the electrical field off (2) and on (3).
This setup allows the effect of the electrostatic deposition to
be determined and the overall diffusional losses in the entire
deposition chamber to be quantified.
Figure 4a shows the number-weighted particle size
distribution of adipic acid aerosol particles for the three
different measurement conditions described in Figure 2b:
bypassing the chamber (black) and passing through the de-
position chamber with the electrical field off (light gray) and
with the electrical field on (gray). A significant fraction of the
particles is lost in the deposition chamber even when the
electrical field is off, as illustrated by the difference between
the black (bypass mode) and light gray (electrical field off)
distributions. An increasing fraction of particles is lost
without electrical field between 30 nm and 50 nm, which is
likely due to turbulence effects within the deposition cham-
ber. Turning on the electrical field leads to a further decrease
of the particles passing through the chamber. Figure 4b dis-
plays the size dependence of the fraction of particles deposited
when the electrical field is on, relative to the particle number
passing through the chamber without electrical field. This is
calculated from four SMPS scans, and the resulting standard
deviations are shown as error bars. Due to low counting sta-
tistics at larger diameters, the error increases strongly with
increasing diameter. The smallest particles (< 20nm) are de-
posited with an efficiency of about 15%, 40–120nm particles
with about 40–45% efficiency, and particles larger than 120nm
with about 30% efficiency. Over a wide particle size range, the
particle deposition efficiency is only weakly dependent on the
particle diameter, which can be explained by the different
deposition processes for small and large particles, i.e., diffu-
sional processes for small particles and impaction for large
particles as described in detail by Savi and co-workers.(15)
In terms of particle mass concentration, 41% of the aerosol
passes the deposition chamber with the electrical field off
and 22% with the electrical field on, relative to the bypass
mode (black distribution in Fig. 4a). Thus, on a mass basis,
19% of the particles entering the deposition chamber are
deposited in the chamber due to the electrical field. How-
ever, these measurements do not allow verifying whether all
these particles are actually deposited on the cell cultures.
This was determined in more detail with the IC/MS method
described below.
Particle deposition efficiency on the cell cultures. For a
detailed quantification of the particles deposited on the cell
cultures, six different experiments were performed (see Table
1). In these experiments, adipic acid particles were quantified
using IC/MS. The variability of the deposition was deter-
mined for two different plates (experiments 1–4, Table 1).
These data were compared with particle deposition without
an electric field (experiment 6) and an experiment where
adipic acid was quantified in the wells and on the counter
electrode, i.e., the mesh of the delivery tubes (experiment 5).
Table 2 lists the results of these experiments. Numbers are
given as fractions of the adipic acid mass deposited relative
to the adipic acid mass entering the deposition chamber (in
percent). Figure 5 shows the average deposition efficiencies
of experiments 1–5 for every well of the plates. The left y-axis
shows the fraction of deposited particle mass in percent. An
FIG. 4. Size-dependent deposition of particles in the depo-
sition chamber. (a) Size distribution of particles bypassing the
deposition chamber (black), passing through the deposition
chamber without electrical field (light gray), and passing
through the deposition chamber with electrical field (gray). (b)
Size-dependent particle fraction deposited in the deposition
chamber due to the electrical field. The y-axis denotes the
relation (N1-N2)/N1 in percent, where N1 is the mean value
of dN/dlogDp of four SMPS scans without electrical field and
N2 the analogous value with electrical field. The error bars
represent the corresponding standard deviations.
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average deposition efficiency of 8.4% with a relative stan-
dard deviation of 24% is observed. The average particle de-
position efficiency was 7.6% (21% relative standard
deviation) onto plate 1 (average of experiments 1, 2, and 5)
and 9.8% (19% relative standard deviation; see Table 2) onto
plate 2 (average of experiments 3 and 4). The difference is
likely due to slight variation in the machining of the two
plates where the distance between the end of the delivery
tubes and the wells is a critical parameter. The average well-
to-well variability of the deposition efficiency is 15.6% (i.e.,
average of the standard deviations of all wells in experiments
1–5; see Table 2) with a standard deviation of 24.7%.
The right y-axis in Figure 5 shows the fraction of particle
mass deposited, considering only the charged particles. The
mode of the adipic acid particles is about 50 nm (Fig. 4a), and
the corresponding mass median diameter (MMD) is about
100 nm. According to Wiedensohler,(20) about 28.5% of 100-
nm particles carry a positive and 28.5% a negative charge at
equilibrium. Thus, about 71.5% are neutral or carry a charge
with the opposite polarity, and therefore are not deposited
on the inserts due to the electrical field. This means that
about 24% of all charged particles are deposited in plate 1
and about 34% in plate 2.
A decreased frequency of switching between positive and
negative polarity could potentially increase the deposition
efficiency (see Fig. 3 in Savi et al.(15)). Therefore, in experiment
5 (Table 2), the frequency was lowered to 1/3Hz compared
with 1Hz (experiments 1–4). No statistically significant
increased deposition could be observed, indicating that for the
geometry of the deposition chamber, 1Hz is an optimal value.
Particle deposition decreased significantly to about 2.7%
when no electrical field was applied (experiment 6), showing
that the electrical field increases the deposition efficiency by
about a factor of 3.1 compared with deposition by diffusion
processes (i.e., with the electrical field off) for particles with
100 nm MMD.
Due to the 85Kr bipolar charger, particles are charged
positively and negatively, which mimics the charge distri-
bution present in the atmosphere. However, this also results
in a limited deposition efficiency on the cell cultures, because
only particles of one polarity are attracted to the cell cultures,
whereas particles of the other polarity are attracted to the
counter electrode, i.e., the metal meshes at the end of the de-
livery tubes. This can be clearly seen in experiment 5 where
the adipic acid concentration was measured in the wells and
on the meshes at the end of the delivery tubes. On average,
about 35% more particles were deposited on the meshes
(12.2– 2.0%) compared with the wells (8.8– 1.3%). The com-
bined deposition efficiency on the meshes and the wells is 21%
(– 2%) and includes particles deposited due to the electrical
field, but also particles that are deposited due to diffusional/
turbulent processes. As described above, about 57% of all 100-
nm particles are charged using a bipolar charger. Assuming
that about half of the particles are lost in the chamber (see Fig.
6 below) and assuming that these losses affect neutral and
charged particles equally, about 74% of the charged particles
Table 1. Overview of Particle Deposition Experiments Analyzed with IC/MS
Experiments 1 & 2 Experiments 3 & 4 Experiment 5 Experiment 6
E-field frequency 1Hz 1Hz 1/3Hz No field
12-well plate number 1 2 1 1
IC/MS analysis All wells All wells All wells, all meshes 4 wells, 4 meshes
Table 2. Deposition Efficiencies from all IC/MS Measurements
Exp. 1 Exp. 2 Exp. 3 Exp. 4 Exp. 5 Exp. 5 Exp. 5 Exp. 6 Exp. 6 Exp. 1 & 2 Exp. 3 & 4
Well Well Well Well Well Mesh Well Mesh
1Hz 1Hz 1Hz 1Hz 1/3Hz 1/3Hz No field No fieldWell/
mesh # Plate 1 Plate 1 Plate 2 Plate 2 Plate 1 Plate 1 Well +mesh Plate 1 Plate 1 Average
% of
charged
particles Average
% of
charged
particles
1 6.4 7.0 12.3 6.7 6.8 11.0 17.7 3.2 2.5 6.7 23.4 9.5 33.1
2 4.8 5.6 10.9 6.8 9.5 10.9 20.4 — — 5.2 18.3 8.9 31.0
3 6.5 6.2 12.1 7.7 7.5 12.5 20.1 — — 6.4 22.3 9.9 34.6
4 6.6 5.7 10.8 8.7 8.9 12.0 20.9 2.2 2.3 6.2 21.6 9.7 34.1
5 6.7 6.1 14.1 8.8 8.8 12.3 21.1 — — 6.4 22.2 11.4 40.0
6 7.9 5.8 10.5 8.8 9.2 11.9 21.1 — — 6.9 24.1 9.6 33.7
7 7.2 4.4 8.9 8.7 8.2 10.6 18.8 — — 5.8 20.3 8.8 30.9
8 7.8 — 9.4 — 9.7 9.2 18.9 3.7 1.7 7.8 27.3 9.4 32.9
9 7.9 5.6 9.5 8.2 6.9 10.7 17.6 — — 6.8 23.7 8.9 31.1
10 7.0 8.8 11.2 9.1 8.9 13.7 22.6 — — 7.9 27.7 10.1 35.5
11 9.8 7.3 11.4 9.0 9.8 14.9 24.6 — — 8.5 29.9 10.2 35.7
12 9.9 8.3 12.1 9.0 11.3 16.4 27.7 1.7 2.3 9.1 31.9 10.5 36.8
Mean 7.4 6.4 11.1 8.3 8.8 12.2 21.0 2.7 2.2 7.0 24.4 9.8 34.1
SD 1.4 1.3 1.4 0.9 1.3 2.0 2.9 0.9 0.3
SD (%) 19 20 13 11 15 16 14 34 15
Fraction of particles deposited on wells and on metal meshes at the end of the delivery tubes. Numbers are given in percent relative to the
total particle mass entering the deposition chamber. The fraction of charged particles is calculated for a mode diameter of 100nm and
assuming that 28.5% of all particles are either positively or negatively charged.(20) For experiment 6, only four wells were analyzed. Plates 1 and
2 refer to two different 12-well plates used to hold the cell culture inserts (see Fig. 1 for details).
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(21% divided by 28.5%) are deposited in the wells and on the
meshes due to the electrical field applied.
Figure 6 summarizes and compares the results from SMPS
and IC/MS measurements. The left bar is derived from
SMPS mass concentration measurements without electrical
field where 41% of the particle mass passes the deposition
chamber (light gray fraction) and 59% is deposited in the
instrument. From the IC/MS measurements, we know that
about 5% of the particles deposit on the meshes and in the
wells if no electrical field is applied (experiment 6). This
fraction is represented by the white part of the bar, and thus
about 54% are lost in other parts of the instrument.
The middle bar shows the SMPS measurements with the
electrical field applied. Here only 22% of the particles exit the
chamber. As the overall diffusional losses in the deposition
chamber are assumed to be the same as for conditions
without electrical field, i.e., 59%, about 19% are deposited on
the wells and the meshes due to the effect of the electrical
field (gray fraction).
The right bar shows the particles deposited as quantified
with the IC/MS technique (experiment 5). Twenty-one per-
cent of the particle mass is deposited on the meshes and the
wells. Diffusional deposition is assumed to account again for
5%, resulting in 16% of the particles deposited due to the
electrical field, which compares well with the 19% deter-
mined from the SMPS experiment (middle bar).
Higher total deposition efficiencies could be reached with
a unipolar charging of the particles as shown by others.(21–23)
De Bruijne et al.(21) report a deposition efficiency of 35–47%,
whereas Sillanpa¨a¨ et al.(23) reached even 95%. Lenz et al.(22)
determined a deposition efficiency of 7.2% for a deposition
chamber, which was developed to investigate the deposition
of nanoparticles in liquids.
Conclusions
We developed and characterized a new instrument to de-
posit aerosol particles onto cell cultures. Within the deposition
chamber, aerosol particles are deposited on cell cultures di-
rectly out of a continuous aerosol flow at realistic physiolog-
ical conditions, i.e., at 36–37C and 90–95% RH. This tool can
be used to investigate the impact of atmospheric, engineered,
as well as therapeutic aerosols on cell cultures. Twelve cell
cultures can be exposed simultaneously, allowing for a larger
number of exposures compared with our previous instru-
ment(15) and other systems described in the literature where
four or less cell cultures are exposed simultaneously.(21,23) The
new deposition chamber is a compact and portable system
allowing for particle sampling at any aerosol source, even
outside a cell biology or particle laboratory.
A key feature of the deposition chamber is the efficient
electrostatic particle deposition on the cell cultures using bi-
polarly charged aerosol particles, which mimics the charge
distribution of particles in the ambient atmosphere.(24) About
24–34% of all charged particles are deposited on the cell cul-
tures, which is about a factor of 3–4 larger than deposition
solely due to diffusional processes for the 100-nm particles
(MMD) (sigma 1.7) used in this study (which is a typical size
for ambient atmospheric aerosol particles). It is expected that
this factor is even more favorable for larger particles, where
diffusional deposition is less efficient. Deposition of particles
of both polarities assures that, on average, no net charge is
deposited on the cells. However, bipolar charging has the
disadvantage that a fraction of the particles always carries
no net charge and is thus not efficiently deposited in our
chamber. The fraction of charged particles is mainly a function
of particle size and varies between about 20% (one polarity)
for 50-nm particles and about 45% for 1,000-nm particles.(20)
The two analytical methods applied in this study to
quantify the deposition efficiency of particles within the
deposition chamber are in good agreement. The variability of
the deposition efficiency between the 12 cell culture wells
was assessed to be between 10% and 20%.
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